Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker
- 1 September 1999
- journal article
- clinical trial
- Published by Wiley in European Journal of Neurology
- Vol. 6 (5), 585-590
- https://doi.org/10.1046/j.1468-1331.1999.650585.x
Abstract
Nitric oxide is formed from L‐arginine by a family of enzymes: nitric oxide synthase (NOS). The inducible nitric oxide synthase is activated by cytokines and it has been suggested that activation of the enzyme gives rise to neurotoxic levels of reactive nitrogen oxides. This enzyme has been shown to be localized in multiple sclerosis (MS) lesions but the role of nitric oxide formation in the pathogenesis of MS is still unclear. Using capillary electrophoresis, we have analysed nitrite and nitrate in cerebrospinal fluid (CSF) and demonstrate increased levels of reactive nitrogen products in 17 patients with MS. The total levels of oxidized nitrogen products were significantly elevated in MS patients when compared with controls. In patients with active MS, nitrite levels were significantly increased when compared with controls and patients in remission. This is supportive of NOS induction in MS. We suggest that capillary electrophoresis analysis of nitrite and nitrate in CSF could provide a clinically useful way to determine disease activity in MS.Keywords
This publication has 30 references indexed in Scilit:
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple SclerosisImmunological Reviews, 1995
- Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brainsAnnals of Neurology, 1994
- Synthesis of nitric oxide in CNS glial cellsTrends in Neurosciences, 1993
- A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compoundsNature, 1993
- DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its ProgenitorsScience, 1991
- Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.The Journal of Experimental Medicine, 1991
- Tumor necrosis factor identified in multiple sclerosis brain.The Journal of Experimental Medicine, 1989
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983